🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Arizona

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Arizona

9 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan Arizona.

Vil nan Arizona

Tèks ofisyèl etid la (Anglè)

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  • Banner MD Anderson Cancer Center, Gilbert
  • Mayo Clinic Hospital in Arizona, Phoenix
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07000084

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

  • Academic Urology and Urogynecology of Arizona, Sun City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06919965

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • Mayo Clinic, Phoenix
  • East Valley Urology Center of Arizona, Queen Creek
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05951179

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

  • East Valley Urology Center of Arizona, Queen Creek
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT07480356

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • University of Arizona - Cancer Center, Tucson
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • Mayo Clinic, Scottsdale
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

  • East Valley Urology Center of Arizona, Mesa
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT05710848

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

  • Arizona Clinical Trials, Chandler
Ap rekriteFaz 1/2
Laj 18 a 85 · Tout sèks · Mizajou Mar 27, 2026 · NCT06800963

Blue Light Cystoscopy With Cysview® Registry

  • Mayo Clinic, Phoenix
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.